Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Antibiotics Market Grown from 2024 to 2025?

Recent years have witnessed robust growth in the antibiotics market. A surge is anticipated from $84.68 billion in 2024 to $89.31 billion in 2025, marking a compound annual growth rate (CAGR) of 5.5%. Several reasons are contributing to the growth over the historic period, including an uptick in infectious diseases incidences, burgeoning population and urbanization, increased awareness about healthcare, improved accessibility to healthcare services, and the widespread presence of antibiotic-resistant strains.

What Growth Rate Is Anticipated for the Antibiotics Market in the Coming Years?

In the coming years, a robust expansion is anticipated for the antibiotics market, with its size projected to reach $110.65 billion in 2029. This growth represents a compound annual growth rate (CAGR) of 5.5%. A variety of factors are expected to drive this growth during the forecasted period. These include global health risks, an uptick in healthcare expenditure, government policies and initiatives, coupled with increased international collaboration. Significant trends influencing this forecasted period are the advancement of oral antibiotics, collaborations and partnerships for antibiotic development, availability of regulatory incentives and pathways, the implementation of antimicrobial stewardship programs within healthcare, as well as worldwide health initiatives promoting access to antibiotics.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11923&type=smp

Who Are the Leading Companies in the Antibiotics Market?

Major companies operating in the antibiotics market include Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol Myers Squibb (BMS), AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim, Viatris Inc, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company, Sun Pharmaceutical Industries Limited, Cipla Ltd., Ferring Pharmaceuticals, Hikma Pharmaceuticals plc, Lupin Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Limited, Basilea Pharmaceutica Ltd., Paratek Pharmaceuticals Inc., Spero Therapeutics Inc., Nabriva Therapeutics Plc

What Are the Key Drivers of the Antibiotics Market?

The antibiotics market is anticipated to advance due to the growing rate of bacterial infections. Bacterial infections are brought about by microscopic single-celled creatures known as bacteria. They are remarkably dealt with and prevented with the aid of antibiotics that restrict bacterial proliferation. For instance, the World Health Organization, a Switzerland-based specialized health agency of the United States, reported in February 2023 that 30 countries worldwide had experienced a cholera outbreak in 2022. The cholera case fatality ratio (CFR) stood at 1.9% in 2021, marking it as the highest in the past ten years. Therefore, the escalating incidence of bacterial infections propels the antibiotics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=11923&type=smp

What Are the Key Market Segments in the Antibiotics Industry?

The antibiotics market covered in this report is segmented –

1) By Drug Class: Penicillin, Cephalosporin, Aminoglycosides, Tetracycline, Macrolides, Fluoroquinolones, Sulfonamides, Other Classes

2) By Spectrum Of Activity: Broad-spectrum Antibiotic, Narrow-spectrum Antibiotic

3) By Route Of Administration: Oral, Intravenous, Other Routes

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

5) By Application: Skin Infections, Respiratory Infections, Urinary Tract Infections, Septicemia, Ear Infections, Gastrointestinal Infections, Other Applications

Subsegments:

1) By Penicillin: Natural Penicillins, Aminopenicillins, Penicillinase-resistant Penicillins, Extended-spectrum Penicillins

2) By Cephalosporin: First-generation, Second-generation, Third-generation, Fourth-generation, Fifth-generation

3) By Aminoglycosides: Gentamicin, Tobramycin, Amikacin, Neomycin

4) By Tetracycline: Tetracycline, Doxycycline, Minocycline, Oxytetracycline

5) By Macrolides: Erythromycin, Azithromycin, Clarithromycin

6) By Fluoroquinolones: Ciprofloxacin, Levofloxacin, Moxifloxacin, Ofloxacin

7) By Sulfonamides: Sulfamethoxazole, Sulfadiazine, Sulfasalazine

8) By Other Classes: Glycopeptides, Lipopeptides, Streptogramins, Polymyxins

What Are the Latest Trends in the Antibiotics Market?

Significant trends emerging in the antibiotics market include the approval of new products. Leading companies in this industry are gaining regulatory authorization for their innovative antibiotic formulations. For exemplification, in January 2023, Zidavi was launched by Alkem Laboratories Ltd., a pharmaceutical entity based in India. Zidavi combines ceftazidime and avibactam and is designed to treat complicated urinary tract infections, intra-abdominal infections, and pneumonia resulting from multi-drug resistant (MDR) Gram-negative bacteria. Zidavi constitutes a vital step in combating antibiotic resistance as it stands among the limited antibiotics capable of efficiency against MDR Gram-negative bacteria.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/antibiotics-global-market-report

What Are the Key Regional Markets in the Antibiotics Industry?

North America was the largest region in the antibiotics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11923

This Report Delivers Insight On:

1. How big is the antibiotics market, and how is it changing globally?

2. Who are the major companies in the antibiotics market, and how are they performing?

3. What are the key opportunities and risks in the antibiotics market right now?

4. Which products or customer segments are growing the most in the antibiotics market?

5. What factors are helping or slowing down the growth of the antibiotics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model